Skip to main content
. 2021 Jul 21;12(1):4123–4135. doi: 10.1080/21655979.2021.1953215

Figure 8.

Figure 8.

Building and validation of the nomogram predicting overall survival for lung adenocarcinoma patients. (a) The nomogram built based on the T stage and risk signature. (b, c) Calibration curves for predicting 1-, 3-, and 5-year survival of LUAD patients